The hepatic IR index (= EGP × fasting insulin 31) was significantly higher in NASH patients (278 ± 52.7 vs. 90.0 ± 14.9 mg/kg/min pmol/ml; p = 0.0024). Here, INS is linked to metabolic dysfunction-associated steatohepatitis.